BioMarin Pharmaceutical Inc. (BMRN)
$54.80-0.16%Close
SELLBEAR · day 24
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $10.6B
- Beta
- 0.24
- P/E (TTM)
- 147.95
- Short % float
- 6.00%
- Days to cover
- 5.5
- SI change
- +14.4%
- 1W
- -4.16%
- 1M
- -16.35%
- vs SPY 1W
- -5.32%
- vs SPY 1M
- -19.34%
Industry peers
FMP comparable companies · ranked by market cap
- VRTXSELLVertex Pharmaceuticals Incorporated$127.7BBEARQ 23$503.25+1.36%
- ALNYSELLAlnylam Pharmaceuticals, Inc.$30.0BRECOVERYQ 28$224.53+3.63%
- INSMSELLInsmed Incorporated$21.8BCRISISQ 13$100.48+0.12%
- ASNDSELLAscendis Pharma A/S$13.8BRECOVERYQ 35$222.69+2.94%
- BBIOSELLBridgeBio Pharma, Inc.$12.7BRECOVERYQ 18$65.04+0.48%
- IONSSELLIonis Pharmaceuticals, Inc.$7.2BRECOVERYQ 8$43.30+4.57%
- PTCTSELLPTC Therapeutics, Inc.$5.2BRECOVERYQ 18$62.56+3.42%
- TVTXSELLTravere Therapeutics, Inc.$4.8BCRISISQ 33$52.04+0.17%
- RAREBUYUltragenyx Pharmaceutical Inc.$1.5BRECOVERYQ -6$15.29+1.24%
- PHARSELLPharming Group N.V.$675MCRISISQ -1$9.53+2.73%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
